Question: Is routine prophylactic granulocyte colony stimulating factor ( GCSF ) necessary with accelerated ( dose dense ) paclitaxel for early breast cancer?
Answer: Accelerated paclitaxel in breast cancer patients without prophylactic GCSF is safe, avoids side effects, reduces costs and is not associated with an increase risk of neutropenic sepsis or treatment delays.